Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.
Saved in:
| Title: | Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis. |
|---|---|
| Authors: | Amir CM; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States., Kapler S; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States., Hoftman GD; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States., Kushan L; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States., Zinberg J; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States., Cadenhead KS; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States., Kennedy L; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States., Cornblatt BA; Department of Psychiatry, Zucker Hillside Hospital, Long Island, NY, United States., Keshavan M; Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Boston, MA, United States., Mathalon DH; Department of Psychiatry, San Francisco Veterans Affairs (SFVA) Medical Center, University of California, San Francisco (UCSF), San Francisco, CA, United States., Perkins DO; Department of Psychiatry, University of North Carolina, Chapel Hill, NC, United States., Stone W; Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Boston, MA, United States., Tsuang MT; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States.; Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA, United States., Walker EF; Departments of Psychology and Psychiatry, Emory University, Atlanta, GA, United States., Woods SW; Department of Psychiatry, Yale University, New Haven, CT, United States., Cannon TD; Department of Psychology, Yale University, New Haven, CT, United States., Addington J; Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada., Bearden CE; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.; Department of Psychology, University of California, Los Angeles (UCLA), Los Angeles, CA, United States. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2023 Apr 20; Vol. 14, pp. 1143315. Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
